Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
CURRENT ASSETS:
Cash	$ 1,210	$ 72,294
Prepaid expenses	746	746
Total current assets	1,956	73,040
Other assets, net	116,495	70,679
Patents, net	445,018	486,932
Total assets	563,469	630,651
CURRENT LIABILITIES:
Accounts payable	323,948	59,160
Convertible notes, net of discount $39,414 and $440,800 respectively	1,033,249	601,250
Derivative liability	1,275,500	653,831
Accrued Liabilities	497,078	343,519
Contract liability, related party	42,000	42,000
Related party notes payable	44,096	44,096
Total current liabilities	3,215,871	1,743,856
Secured Debenture	1,155,150	1,102,243
Total liabilities	4,371,021	2,846,099
Commitments and contingencies
STOCKHOLDERS' DEFICIT
Convertible preferred stock - Class D (par value $0.01; 100,000 shares authorized; 88,235 issued and outstanding at December 31, 2019 and, 2018, respectively)	883	883
Common stock (par value $0.01), 20,000,000,000 shares authorized, 1,392,042,112 and 89,680,567 shares issued and outstanding at December 31, 2019 and, 2018, respectively	13,920,421	896,806
Treasury stock, 100,000 shares at December 31, 2019 and December 31, 2018	(1,000)	(1,000)
Paid-in capital in excess of par value	(11,877,864)	859,481
Non-controlling interest in a variable interest entity and subsidiary	(12,439)	(12,439)
Accumulated other comprehensive income	336,775	389,680
Accumulated deficit	(6,174,328)	(4,348,859)
TOTAL STOCKHOLDERS' DEFICIT	(3,807,552)	(2,215,448)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 563,469	$ 630,651